141 related articles for article (PubMed ID: 15527327)
1. Use of TP53 reference materials to validate mutations in clinical tissue specimens by single-strand conformational polymorphism analysis.
Sunar-Reeder B; Atha DH; Aydemir S; Reeder DJ; Tully L; Khan AR; O'Connell CD
Mol Diagn; 2004; 8(2):123-30. PubMed ID: 15527327
[TBL] [Abstract][Full Text] [Related]
2. Renewable standard reference material for the detection of TP53 mutations.
O'Connell CD; Tully LA; Devaney JM; Marino MA; Jakupciak JP; Atha DH
Mol Diagn; 2003; 7(2):85-97. PubMed ID: 14580228
[TBL] [Abstract][Full Text] [Related]
3. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
[TBL] [Abstract][Full Text] [Related]
4. Identification of known p53 point mutations by capillary electrophoresis using unique mobility profiles in a blinded study.
Wenz HM; Ramachandra S; O'Connell CD; Atha DH
Mutat Res; 1998 May; 382(3-4):121-32. PubMed ID: 9691993
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-based polymerase chain reaction-single-strand conformation polymorphism analysis of p53 gene by capillary electrophoresis.
Katsuragi K; Kitagishi K; Chiba W; Ikeda S; Kinoshita M
J Chromatogr A; 1996 Sep; 744(1-2):311-20. PubMed ID: 8843680
[TBL] [Abstract][Full Text] [Related]
6. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
7. Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism.
O'Connell CD; Tian J; Juhasz A; Wenz HM; Atha DH
Electrophoresis; 1998 Feb; 19(2):164-71. PubMed ID: 9548275
[TBL] [Abstract][Full Text] [Related]
8. Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assay.
Shi XB; Bodner SM; deVere White RW; Gumerlock PH
Diagn Mol Pathol; 1996 Dec; 5(4):271-8. PubMed ID: 8955619
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
10. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.
Vos M; Adams CH; Victor TC; van Helden PD
Cancer Genet Cytogenet; 2003 Jan; 140(1):23-30. PubMed ID: 12550754
[TBL] [Abstract][Full Text] [Related]
12. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis.
Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S
Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.
Saed GM; Ladin D; Olson J; Han X; Hou Z; Fivenson D
Arch Dermatol; 1998 Aug; 134(8):963-7. PubMed ID: 9722726
[TBL] [Abstract][Full Text] [Related]
15. [Detection of point mutation in p53 gene by capillary electrophoresis-PCR-SSCP analysis].
Liu J; Jing H; Ru Q; Deng Y; Luo G; Huang Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):476-9. PubMed ID: 12910694
[TBL] [Abstract][Full Text] [Related]
16. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.
Ricevuto E; Ficorella C; Fusco C; Cannita K; Tessitore A; Toniato E; Gabriele A; Frati L; Marchetti P; Gulino A; Martinotti S
Am J Pathol; 1996 Feb; 148(2):405-13. PubMed ID: 8579104
[TBL] [Abstract][Full Text] [Related]
18. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations.
Moore L; Godfrey T; Eng C; Smith A; Ho R; Waldman FM
Biotechniques; 2000 May; 28(5):986-92. PubMed ID: 10818706
[TBL] [Abstract][Full Text] [Related]
19. Detection of TP53 gene mutations in human sarcomas.
Castresana JS; Rubio MP; Gómez L; Kreicbergs A; Zetterberg A; Barrios C
Eur J Cancer; 1995; 31A(5):735-8. PubMed ID: 7640047
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature.
Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ
Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
